| 1 | YASVBOM0083940 | PHARMACEUTICAL PRODUCT | GLENMARK THERAPEUTICS INC., USA | GLENMARK PHARMACEUTICALS LTD. | 18 oct. 2026 | India | 8,916 kg | 18 PKG |
| 2 | YASVBOM0083939 | PHARMACEUTICAL PRODUCT | GLENMARK THERAPEUTICS INC., USA | GLENMARK PHARMACEUTICALS LTD. | 18 oct. 2026 | India | 6,195 kg | 40 PKG |
| 3 | YASVBOM0083938 | PHARMACEUTICAL PRODUCT | GLENMARK THERAPEUTICS INC., USA | GLENMARK PHARMACEUTICALS LTD. | 18 oct. 2026 | India | 9,880 kg | 46 PKG |
| 4 | YASVBOM0083931 | PHARMACEUTICAL PRODUCT | GLENMARK THERAPEUTICS INC., USA | GLENMARK PHARMACEUTICALS LTD. | 18 oct. 2026 | India | 11,204 kg | 46 PKG |
| 5 | YASVBOM0083941 | PHARMACEUTICAL PRODUCT | GLENMARK THERAPEUTICS INC., USA | GLENMARK PHARMACEUTICALS LTD. | 18 oct. 2026 | India | 7,966 kg | 36 PKG |
| 6 | MAEU276710042 | 18 PACKAGES 2205 CARTONS PHARMACEUTICALS AS UNDER FLUTICASONE PROP NS 50MCG 120MD NDC CODE68462091820 FDA XXXXXXXXXXXX 63 B C Q 25 H.T. S NO.3004.32.0080 ANDA NO.219232 THERAPEU TICE USE NASAL STEROID TO TREAT NASAL SYMPTOMS SUCH AS CONGESTION SNEEZING ITCHING AND RUNNY NOSE CAUSED BY ALLERGIES (SEASONAL OR PERE, NNIAL) AND NONALLERGIC RHINITIS. FLUTICASONEPROP NS 50MCG 120MD NDC CODE68462091820 FDA XXXXXXXXXXXX 63 B C Q 25 H. T. S NO.3004.32.0080 ANDA NO.219232 THERAPEUTICE USE NASAL STEROID TO TREAT NASAL SYMPTOMS SUCH AS CONGESTION SNEEZING ITCHING AND RUNNY NOSE CAUSED BY ALLERGIES (SEASONAL OR PERENNIAL) AND NONALLERGIC RHINITIS. FLUTICASONE PROP NS 50MCG 120MD NDC CODE68462091820 FDA XXXXXXXXXXXX 63 B C Q 25 H. T. S NO.3004.32.0080 ANDA NO.219232THERAPEUTICE USE NASAL STEROID TO TREAT NASA L SYMPTOMS SUCH AS CONGESTION SNEEZING ITCHING AND RUNNY NOSE CAUSED BY ALLERGIES (SEASONAL OR PERENNIAL) AND NONALLERGIC RHINITIS. COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT.16.09.2026 F22700001763 DT. 16.09.2026 F22700001764 DT. 16.09.2026 SBILL NO 6892122 DT 16SEP2026 SBILL NO 6892133 DT 16SEP2026 SBILL NO 6892125 DT 16SEP2026 GROSS WT.8647.200 KGSNET WT.6456.240 KGS 18 DATA LOGGERS SET T EMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES NOTIFY PARTY2 XXXXXXXX | GLENMARK PHARMACEUTICALS INC.,USA | GLENMARK PHARMACEUTICALS LIMITED | 13 oct. 2026 | India | 8,665 kg | 18 PKG |
| 7 | MAEU276716517 | 46 PACKAGES 2947 CARTONS PHARMACEUTICALS AS UNDER ONDANSETRON ODT 4MG 30UD NDC CODE68462015713 FDA XXXXXXXXXXXX NO61 T C A 26 H. T. S NO. 3004.90.92.40 ANDA NO.78152 THERAPEUTICE USEANTI EMETIC GABAPENTIN TAB 600MG 500 NDCCODE68462012605 FDA XXXXXXXXXXXXXX 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.77662 THERAPE, UTICE USEANTICONVULSANT NAPROXEN TAB 500MG 100 NDC CODE68462019001 FDA XXXXXXXXXXXX NO.62G C A 49 H. T. S NO. 3004.90.92.40 ANDA NO.7 8250 THERAPEUTICE USEANTIINFLAMMATORY ANALGESIC NAPROXEN TAB 500MG 500 NDC CODE68462019005 FDA XXXXXXXXXXXX NO.62 G C A 49 H. T. S NO.3004.90.92.40 ANDA NO.78250 THERAPEUTICE USE ANTIINFLAMMATORY ANALGESIC COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 17.09.2026 F22752002530 DT. 17.09.2026 SBILL NO 6917573 DT 17SEP2026 SBILL NO 6918016 DT 17SEP2026 GROSS WT.9992.313 KGS NET WT.8073.756 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES NOTIFY PARTY2 XXXXXXXXXXXXXXXXXXXXXXXXXXX0 USA | GLENMARK PHARMACEUTICALS INC.,USA | GLENMARK PHARMACEUTICALS LTD | 13 oct. 2026 | India | 10,013 kg | 46 PKG |
| 8 | MAEU276716513 | 44 PACKAGES 2512 CARTONS PHARMACEUTICALS AS UNDER NAPROXEN TAB 500MG 100 NDC CODE68462019001 FDA XXXXXXXXXXXX NO.62 G C A 49 H. T. S NO. 3004.90.92.40 ANDA NO.78250 THERAPEUTICE USEANTIINFLAMMATORY ANALGESIC NAPROXEN TAB 500MG 500 NDC CODE68462019005 FDA XXXXXXXXXXXX NO.62 G C A 49 H. T. S NO. 3004.90.92.40 ANDA, NO.78250 THERAPEUTICE USEANTIINFLAMMATORY AN ALGESIC ONDANSETRON ODT 4MG 30UD NDC CODE68462015713 FDA XXXXXXXXXXXX NO61 T C A 26 H. T.S NO. 3004.90.92.40 ANDA NO.78152 THERAPEUTI CE USEANTI EMETIC MUPIROCIN OINT 2 22GM NDC CODE68462018022 FDA XXXXXXXXXXXX NO. 61 G J J81 H. T. S NO. 3004.90.92.45 ANDA NO. 90480 THERAPEUTICE USE ANTIBACTERIAL COMMERCIALCUSTOM INVOICE NO. XXXXXXXXXXXX DT. 15.09.2026 F22752002515 DT. 15.09.2026 F22752002516 DT. 15.09.2026 SBILL NO 6874514 DT 16SEP2026 SBILL NO 6875302 DT 16SEP2026 SBILL NO 6874505 DT 16SEP2026 GROSS WT.8237.370 KGS NET WT.6231.320 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC.,USA | GLENMARK PHARMACEUTICALS LTD | 13 oct. 2026 | India | 8,255 kg | 44 PKG |
| 9 | MAEU276102279 | TOTAL 84 PALLETS STC 1683 CARTONS ONLYPHARMACUETICAL XXXXXXXXXXXXX V3 TABLETS 3S 3 APPLICATORESOZ 20 MG TABLETS 3X10SCANDID B CREAM 15GMCANDIDERM CREAM 15GMMOMATE CREAM 15 GMESOZ 40 MG TABLETS 3X10SCANDID B LOTION 15 MLCANDID CREAM 20 GMCANDID MOUTH PAINT 15 MLCELAMINACREAM 20GMAIRTEC FB 6200MCG 1SCANDID B CREAM, 30 GMCANDID V GEL 30 GM 6 APPLICATORTELMA T ABLETS 40MG 3X10STELMA TABLETS 80MG 3X10SXMETER 500 TABLETS 10X10SCANDITRAL CAPSULES 7X4 SRELCER GEL 180 MLCANDID POWDER 100 GMCANDIDERM CREAM 30GMALTACEF 250 MG TABLETS 10SALTACEF 500 MG TABS 10SXMET 500MG TABLETS 10X10SASCORIL EXPECTORANT 100MLRELCER GEL 60 MLKETOPLUS SHAMPOO 60 MLCANDID LOTION 20MLGLEVO I.V. 100MLCANDID V6 TABLETS 1X6S 6 APPLICATORGLEVO500 MG TABLETS 1X5SKETOPLUS SHAMPOO 120MLTEL MA 80H TAB 3X10SFLUSORT NASAL SPRAY 50 MCG 120MDDERIVA C GEL 15 GMECZIDERM S OINTMENT 15 GMSUPIROCIN OINTMENT 15GMCOMMERCIAL INVOICE NOXXXXXXXXXXXX DT. 30.06.2026F22700000953 DT. 30.06.2026F22700000954 DT. 30.06.2026SAP INVOICE NO2169551081 DT. 30.06.20262169551035 DT.30.06.20262169551037 DT. 30.06.2026SBILL NO6 246867 DT 25AUG2026SBILL NO6246842 DT 25AUG2026SBILL NO6246896 DT 25AUG2026HSN CODE NO 3004902930042039 30049079 300490993004503130043200 30042099 30049039 30049087 30043190GROSSWEIGHT(KGS) 18689.000 NET WEIGHT(KGS) 15195. 880 FREIGHT PREPAID TOTAL 84 PALLETS STC 1683 CARTONS ONLYPHARMACUETICAL XXXXXXXXXXXXX V3 TABLETS 3S 3 APPLICATORESOZ 20 MG TABLETS 3X10SCANDID B CREAM 15GMCANDIDERM CREAM 15GMMOMATE CREAM 15 GMESOZ 40 MG TABLETS 3X10SCANDID B LOTION 15 MLCANDID CREAM 20 GMCANDID MOUTH PAINT 15 MLCELAMINACREAM 20GMAIRTEC FB 6200MCG 1SCANDID B CREAM, 30 GMCANDID V GEL 30 GM 6 APPLICATORTELMA T ABLETS 40MG 3X10STELMA TABLETS 80MG 3X10SXMETER 500 TABLETS 10X10SCANDITRAL CAPSULES 7X4 SRELCER GEL 180 MLCANDID POWDER 100 GMCANDIDERM CREAM 30GMALTACEF 250 MG TABLETS 10SALTACEF 500 MG TABS 10SXMET 500MG TABLETS 10X10SASCORIL EXPECTORANT 100MLRELCER GEL 60 MLKETOPLUS SHAMPOO 60 MLCANDID LOTION 20MLGLEVO I.V. 100MLCANDID V6 TABLETS 1X6S 6 APPLICATORGLEVO500 MG TABLETS 1X5SKETOPLUS SHAMPOO 120MLTEL MA 80H TAB 3X10SFLUSORT NASAL SPRAY 50 MCG 120MDDERIVA C GEL 15 GMECZIDERM S OINTMENT 15 GMSUPIROCIN OINTMENT 15GMCOMMERCIAL INVOICE NOXXXXXXXXXXXX DT. 30.06.2026F22700000953 DT. 30.06.2026F22700000954 DT. 30.06.2026SAP INVOICE NO2169551081 DT. 30.06.20262169551035 DT.30.06.20262169551037 DT. 30.06.2026SBILL NO6 246867 DT 25AUG2026SBILL NO6246842 DT 25AUG2026SBILL NO6246896 DT 25AUG2026HSN CODE NO 3004902930042039 30049079 300490993004503130043200 30042099 30049039 30049087 30043190GROSSWEIGHT(KGS) 18689.000 NET WEIGHT(KGS) 15195. 880 FREIGHT PREPAID | T. GEDDES GRANT LTD | GLENMARK PHARMACEUTICALS LIMITED | 9 oct. 2026 | Morocco | 18,728 kg | 84 CTN |
| 10 | MAEU275928130 | PART OF FCL 24 PACKAGES 1879 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 NDC CODE68462012605 FDA XXXXXXXXXXXXXX 61 N CA 69 HTS NO.3004.90.9236 ANDA NO.77662 THERA PEUTICE USEANTICONVULSANT BISOPROLOLHCTZ TAB56.25MG 100 NDC CODE68462087901 FDA XXXXXXXXXNO.215995 THERAPEUTICE USEBISOPROLOL FUMARATE, AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATE D IN THE MANAGEMENT OF HYPERTENSION. TACROLIMUS CAP 5MG 100 NDC CODE68462068701 HTS NO 3004.90.92.15 FDA CODE 64 T C E 08 ANDA NO.206662 THERAPEUTICE USE TO PREVENT REJECTION OF A KIDNEY HEART OR LIVER TRANSPLANT BISOPROLOLHCTZ TAB 2.56.25MG 100 NDC CODE68462087801 FDA XXXXXXXXXXXX NO 62 O D A 18 HTS NO.3004.49.0010 ANDA NO.215995 THERAPEUTICE USEBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION. SAXAGLIPTIN TAB 5MG 30 NDC CODE68462072730 FDA XXXXXXXXXXXX NO.61 P C A 99 H. T. S NO.3004.90.9220 ANDA NO.205994 THERAPEUTICE USE ANTIDIABETIC AGENT CARVEDILOL TAB 25MG 100 NDC CODE68462016501 FDA XXXXXXXXXXXX NO 62 OC A 22 HTS NO.3004.90.9221 ANDA NO.78251 THERAPEUTICE USEBETA ADRENOACEPTOR ANTAGONIST COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT.30.08.2026 F22787000809 DT. 30.08.2026 F2278 7000823 DT. 31.08.2026 F22787000830 DT. 31.08.2026 F22787000832 DT. 31.08.2026 GROSS WT.6443.724 KGS NET WT.4850.791 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES SBILL NO 6466890 DT01SEP26 SBILL NO 6466799 DT01SEP26 SBILL NO 6467037 DT01SEP26 SBILL NO 6466886 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX | GLENMARK PHARMACEUTICALS INC.,USA | GLENMARK PHARMACEUTICALS LIMITED | 7 oct. 2026 | Oman | 6,457 kg | 24 PKG |